Deferoxamine Mesylate 60505-6237-06

Package NDC

60505-6237-06

Manufacturer: Apotex Corp.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intramuscular And Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 5, 2021
Listing Expires: December 31, 2027
Application: ANDA207384

Need to source Deferoxamine Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Deferoxamine Mesylate	2 g/1

Drug Class

Iron Chelating Activity [MoA]Iron Chelator [EPC]

Selected Package

60505-6237-06Selected

4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6)